Thrasyvoulos Tzellos, Synne Ildahl Svendsen, Mari Øvergaard, Eldrid Oftestad, Mari Lahelma, Anna-Kaisa Asikainen, Randeep Mandla
{"title":"不同级别医疗机构对特应性皮炎的护理和管理质量--基于调查的患者体验。","authors":"Thrasyvoulos Tzellos, Synne Ildahl Svendsen, Mari Øvergaard, Eldrid Oftestad, Mari Lahelma, Anna-Kaisa Asikainen, Randeep Mandla","doi":"10.1177/23743735241272206","DOIUrl":null,"url":null,"abstract":"<p><p>Atopic dermatitis (AD) is a chronic and fluctuating disease. Optimal management of AD and related comorbidities requires seamless coordination across multiple layers of the healthcare system. The objective of this survey was to explore patients' experiences with current management of AD. Out of 251 responders to this anonymous survey, 76% reported to have moderate or severe AD. Sixty-nine percent with moderate and 45% with severe AD were followed up at primary care level only. Use of advanced systemic treatment options was rare, and the majority experienced itch (97%), dry skin, rash, negative impact on self-esteem and comorbidities despite ongoing treatment. Only 36% received a treatment plan, more often in secondary (78.3%) than primary care (25.0%). Forty-three percent did not know who was responsible for their follow-up and 54% felt no one was responsible. Treatment options were commonly not known or understood. The survey results demonstrate undertreatment, lack of a holistic approach for management of AD. A national pathway including clear referral criteria and timelines can streamline management of AD across multiple levels of the healthcare system.</p>","PeriodicalId":45073,"journal":{"name":"Journal of Patient Experience","volume":"11 ","pages":"23743735241272206"},"PeriodicalIF":1.6000,"publicationDate":"2024-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11307345/pdf/","citationCount":"0","resultStr":"{\"title\":\"Quality of Care and Management of Atopic Dermatitis Across Different Levels of Healthcare-A Survey-Based Patient Experience.\",\"authors\":\"Thrasyvoulos Tzellos, Synne Ildahl Svendsen, Mari Øvergaard, Eldrid Oftestad, Mari Lahelma, Anna-Kaisa Asikainen, Randeep Mandla\",\"doi\":\"10.1177/23743735241272206\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Atopic dermatitis (AD) is a chronic and fluctuating disease. Optimal management of AD and related comorbidities requires seamless coordination across multiple layers of the healthcare system. The objective of this survey was to explore patients' experiences with current management of AD. Out of 251 responders to this anonymous survey, 76% reported to have moderate or severe AD. Sixty-nine percent with moderate and 45% with severe AD were followed up at primary care level only. Use of advanced systemic treatment options was rare, and the majority experienced itch (97%), dry skin, rash, negative impact on self-esteem and comorbidities despite ongoing treatment. Only 36% received a treatment plan, more often in secondary (78.3%) than primary care (25.0%). Forty-three percent did not know who was responsible for their follow-up and 54% felt no one was responsible. Treatment options were commonly not known or understood. The survey results demonstrate undertreatment, lack of a holistic approach for management of AD. A national pathway including clear referral criteria and timelines can streamline management of AD across multiple levels of the healthcare system.</p>\",\"PeriodicalId\":45073,\"journal\":{\"name\":\"Journal of Patient Experience\",\"volume\":\"11 \",\"pages\":\"23743735241272206\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2024-08-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11307345/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Patient Experience\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/23743735241272206\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Patient Experience","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/23743735241272206","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
摘要
特应性皮炎(AD)是一种慢性波动性疾病。特应性皮炎及相关合并症的最佳治疗需要医疗保健系统多层次的无缝协调。本次调查的目的是了解患者对当前 AD 管理的体验。在这项匿名调查的 251 名受访者中,76% 的人表示患有中度或重度注意力缺失症。69%的中度和45%的重度AD患者仅在初级保健机构接受随访。尽管正在接受治疗,但大多数人仍有瘙痒(97%)、皮肤干燥、皮疹、自尊心受到负面影响以及合并症等症状。只有 36% 的患者接受了治疗计划,接受二级治疗的比例(78.3%)高于接受一级治疗的比例(25.0%)。43%的人不知道谁负责他们的后续治疗,54%的人认为没有人负责。人们普遍不知道或不了解治疗方案。调查结果表明,对注意力缺失症的治疗不足,缺乏整体管理方法。包括明确的转诊标准和时间表在内的全国性路径可简化多级医疗保健系统对注意力缺失症的管理。
Quality of Care and Management of Atopic Dermatitis Across Different Levels of Healthcare-A Survey-Based Patient Experience.
Atopic dermatitis (AD) is a chronic and fluctuating disease. Optimal management of AD and related comorbidities requires seamless coordination across multiple layers of the healthcare system. The objective of this survey was to explore patients' experiences with current management of AD. Out of 251 responders to this anonymous survey, 76% reported to have moderate or severe AD. Sixty-nine percent with moderate and 45% with severe AD were followed up at primary care level only. Use of advanced systemic treatment options was rare, and the majority experienced itch (97%), dry skin, rash, negative impact on self-esteem and comorbidities despite ongoing treatment. Only 36% received a treatment plan, more often in secondary (78.3%) than primary care (25.0%). Forty-three percent did not know who was responsible for their follow-up and 54% felt no one was responsible. Treatment options were commonly not known or understood. The survey results demonstrate undertreatment, lack of a holistic approach for management of AD. A national pathway including clear referral criteria and timelines can streamline management of AD across multiple levels of the healthcare system.